{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T17:48:51Z","timestamp":1778780931327,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2016\/000965"],"award-info":[{"award-number":["ECR\/2016\/000965"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00432-022-04130-x","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T10:13:38Z","timestamp":1656670418000},"page":"3421-3436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-3155","authenticated-orcid":false,"given":"Sudeshna","family":"Rakshit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8811-3565","authenticated-orcid":false,"given":"Jithin S.","family":"Sunny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-6144","authenticated-orcid":false,"given":"Melvin","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-8211","authenticated-orcid":false,"given":"Luke Elizabeth","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. V.","family":"Leela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-6688","authenticated-orcid":false,"given":"Koustav","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"issue":"27","key":"4130_CR1","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1200\/JCO.2013.55.0491","volume":"32","author":"S Adams","year":"2014","unstructured":"Adams S, Gray RJ, Demaria S et al (2014) Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 32(27):2959\u20132966. https:\/\/doi.org\/10.1200\/JCO.2013.55.0491","journal-title":"J Clin Oncol"},{"issue":"7","key":"4130_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/abbs\/gmw052","volume":"48","author":"Q Al-Hadid","year":"2016","unstructured":"Al-Hadid Q, Yang Y (2016) R-loop: an emerging regulator of chromatin dynamics. Acta Biochim Biophys Sin (shanghai) 48(7):623\u2013631. https:\/\/doi.org\/10.1093\/abbs\/gmw052","journal-title":"Acta Biochim Biophys Sin (shanghai)"},{"issue":"3","key":"4130_CR3","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3892\/ijo.2015.3075","volume":"47","author":"MD Allen","year":"2015","unstructured":"Allen MD, Jones LJ (2015) The role of inflammation in progression of breast cancer: friend or foe? (Review). Int J Oncol 47(3):797\u2013805. https:\/\/doi.org\/10.3892\/ijo.2015.3075","journal-title":"Int J Oncol"},{"issue":"3","key":"4130_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/s0039-6060(96)80120-6","volume":"119","author":"K Anan","year":"1996","unstructured":"Anan K, Morisaki T, Katano M et al (1996) Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery 119(3):333\u2013339. https:\/\/doi.org\/10.1016\/s0039-6060(96)80120-6","journal-title":"Surgery"},{"key":"4130_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics 4:2. https:\/\/doi.org\/10.1186\/1471-2105-4-2","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"4130_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13(11):674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"4130_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pag\u00e8s F, Trajanoski Z, Galon J (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25(8):1091\u20131093. https:\/\/doi.org\/10.1093\/bioinformatics\/btp101","journal-title":"Bioinformatics"},{"issue":"6","key":"4130_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (Published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313)","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4130_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0046-8177(95)90119-1","volume":"26","author":"LF Brown","year":"1995","unstructured":"Brown LF, Berse B, Jackman RW et al (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 26(1):86\u201391. https:\/\/doi.org\/10.1016\/0046-8177(95)90119-1","journal-title":"Hum Pathol"},{"issue":"1","key":"4130_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lin Y, Shu Y, He J, Gao W (2020) Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer. Mol Cancer 19(1):94. https:\/\/doi.org\/10.1186\/s12943-020-01207-4 (Published 2020 May 22)","journal-title":"Mol Cancer"},{"issue":"3","key":"4130_CR11","first-page":"303","volume":"49","author":"AM C\u00eempean","year":"2008","unstructured":"C\u00eempean AM, Raica M, Suciu C, T\u0103tucu D, S\u00e2rb S, Mure\u015fan AM (2008) Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma. Rom J Morphol Embryol 49(3):303\u2013308","journal-title":"Rom J Morphol Embryol"},{"issue":"6917","key":"4130_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867. https:\/\/doi.org\/10.1038\/nature01322","journal-title":"Nature"},{"key":"4130_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijcard.2019.05.051","volume":"291","author":"M D'Souza","year":"2019","unstructured":"D\u2019Souza M, Schou M, Skals R et al (2019) Polygenic predisposition to breast cancer and the risk of coronary artery disease. Int J Cardiol 291:145\u2013151. https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.051","journal-title":"Int J Cardiol"},{"issue":"12","key":"4130_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrc3627","volume":"13","author":"HL Goel","year":"2013","unstructured":"Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13(12):871\u2013882. https:\/\/doi.org\/10.1038\/nrc3627","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"4130_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/hum.2015.074","volume":"26","author":"JL Gori","year":"2015","unstructured":"Gori JL, Hsu PD, Maeder ML, Shen S, Welstead GG, Bumcrot D (2015) Delivery and specificity of CRISPR-Cas9 genome editing technologies for human gene therapy. Hum Gene Ther 26(7):443\u2013451. https:\/\/doi.org\/10.1089\/hum.2015.074","journal-title":"Hum Gene Ther"},{"issue":"5","key":"4130_CR16","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"10074","key":"4130_CR17","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M (2017) Breast cancer. Lancet 389(10074):1134\u20131150. https:\/\/doi.org\/10.1016\/S0140-6736(16)31891-8","journal-title":"Lancet"},{"issue":"3\u20134","key":"4130_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41417-020-00208-1","volume":"28","author":"X He","year":"2021","unstructured":"He X, Tan L, Ni J, Shen G (2021) Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer. Cancer Gene Ther 28(3\u20134):188\u2013196. https:\/\/doi.org\/10.1038\/s41417-020-00208-1","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"4130_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00262-015-1777-2","volume":"65","author":"HJ Hong","year":"2016","unstructured":"Hong HJ, Lim HX, Song JH et al (2016) Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions. Cancer Immunol Immunother 65(1):61\u201372. https:\/\/doi.org\/10.1007\/s00262-015-1777-2","journal-title":"Cancer Immunol Immunother"},{"issue":"8828","key":"4130_CR20","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/0140-6736(92)93150-l","volume":"340","author":"ER Horak","year":"1992","unstructured":"Horak ER, Leek R, Klenk N et al (1992) Angiogenesis, assessed by platelet\/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340(8828):1120\u20131124. https:\/\/doi.org\/10.1016\/0140-6736(92)93150-l","journal-title":"Lancet"},{"issue":"10","key":"4130_CR21","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/s41416-021-01514-7","volume":"125","author":"N J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen N, Hviid TVF, Nielsen LB et al (2021) Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer. Br J Cancer 125(10):1388\u20131398. https:\/\/doi.org\/10.1038\/s41416-021-01514-7","journal-title":"Br J Cancer"},{"issue":"1","key":"4130_CR22","first-page":"136","volume":"2","author":"ML Kayton","year":"2001","unstructured":"Kayton ML, Libutti SK (2001) Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature. Curr Opin Investig Drugs 2(1):136\u2013138","journal-title":"Curr Opin Investig Drugs"},{"issue":"8","key":"4130_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040960","volume":"7","author":"YW Kim","year":"2012","unstructured":"Kim YW, Kwon C, Liu JL, Kim SH, Kim S (2012) Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma. PLoS ONE 7(8):e40960. https:\/\/doi.org\/10.1371\/journal.pone.0040960","journal-title":"PLoS ONE"},{"issue":"25","key":"4130_CR24","doi-asserted-by":"publisher","first-page":"23028","DOI":"10.1074\/jbc.M101544200","volume":"276","author":"YG Ko","year":"2001","unstructured":"Ko YG, Park H, Kim T, Lee JW, Park SG, Seol W, Kim JE, Lee WH, Kim SH, Park JE, Kim S (2001) A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem 276(25):23028\u201323033. https:\/\/doi.org\/10.1074\/jbc.M101544200","journal-title":"J Biol Chem"},{"issue":"9","key":"4130_CR25","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","volume":"26","author":"GJ Koelwyn","year":"2020","unstructured":"Koelwyn GJ, Newman AAC, Afonso MS et al (2020) Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat Med 26(9):1452\u20131458. https:\/\/doi.org\/10.1038\/s41591-020-0964-7","journal-title":"Nat Med"},{"issue":"1","key":"4130_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao J, Bai J et al (2019) Molecular characterization and clinical relevance of m6A regulators across 33 cancer types. Mol Cancer 18(1):137. https:\/\/doi.org\/10.1186\/s12943-019-1066-3 (Published 2019 Sep 14)","journal-title":"Mol Cancer"},{"issue":"22","key":"4130_CR27","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.7150\/jca.35053","volume":"10","author":"L Liu","year":"2019","unstructured":"Liu L, Liu X, Dong Z et al (2019) N6-methyladenosine-related genomic targets are altered in breast cancer tissue and associated with poor survival. J Cancer 10(22):5447\u20135459. https:\/\/doi.org\/10.7150\/jca.35053 (Published 2019 Aug 29)","journal-title":"J Cancer"},{"issue":"10087","key":"4130_CR28","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","volume":"389","author":"S Loibl","year":"2017","unstructured":"Loibl S, Gianni L (2017) HER2-positive breast cancer. Lancet 389(10087):2415\u20132429. https:\/\/doi.org\/10.1016\/S0140-6736(16)32417-5","journal-title":"Lancet"},{"issue":"24","key":"4130_CR29","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.4161\/cc.22810","volume":"11","author":"HS Madapura","year":"2012","unstructured":"Madapura HS, Salamon D, Wiman KG et al (2012) p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP. Cell Cycle 11(24):4563\u20134569. https:\/\/doi.org\/10.4161\/cc.22810","journal-title":"Cell Cycle"},{"issue":"6","key":"4130_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/jcp.55.6.461","volume":"55","author":"T Megha","year":"2002","unstructured":"Megha T, Ferrari F, Benvenuto A et al (2002) p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J Clin Pathol 55(6):461\u2013466. https:\/\/doi.org\/10.1136\/jcp.55.6.461","journal-title":"J Clin Pathol"},{"issue":"8","key":"4130_CR31","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"LS Mehta","year":"2018","unstructured":"Mehta LS, Watson KE, Barac A et al (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American heart association. Circulation 137(8):e30\u2013e66. https:\/\/doi.org\/10.1161\/CIR.0000000000000556 (Published correction appears in Circulation. 2019 Aug 27;140(9):e543)","journal-title":"Circulation"},{"key":"4130_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13072-015-00406","volume":"8","author":"J Nadel","year":"2015","unstructured":"Nadel J, Athanasiadou R, Lemetre C, Wijetunga NA, Broin P\u00d3, Sato H, Zhang Z, Jeddeloh J, Montagna C, Golden A, Seoighe C, Greally JM (2015) RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships. Epigenetics Chromatin 8:46. https:\/\/doi.org\/10.1186\/s13072-015-00406","journal-title":"Epigenetics Chromatin"},{"issue":"10","key":"4130_CR33","first-page":"869","volume":"7","author":"AI Neugut","year":"1998","unstructured":"Neugut AI, Rosenberg DJ, Ahsan H et al (1998) Association between coronary heart disease and cancers of the breast, prostate, and colon. Cancer Epidemiol Biomarkers Prev 7(10):869\u2013873","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"47","key":"4130_CR34","doi-asserted-by":"publisher","first-page":"45243","DOI":"10.1074\/jbc.M207934200","volume":"277","author":"SG Park","year":"2002","unstructured":"Park SG, Kang YS, Ahn YH, Lee SH, Kim KR, Kim KW, Koh GY, Ko YG, Kim S (2002) Dose-dependent biphasi activity of tRNA synthetase-associating factor, p43, in angiogenesis. J Biol Chem 277(47):45243\u201345248. https:\/\/doi.org\/10.1074\/jbc.M207934200","journal-title":"J Biol Chem"},{"issue":"2","key":"4130_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0002-9440(10)62262-6","volume":"166","author":"SG Park","year":"2005","unstructured":"Park SG, Shin H, Shin YK, Lee Y, Choi EC, Park BJ, Kim S (2005) The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am J Pathol 166(2):387\u2013398. https:\/\/doi.org\/10.1016\/S0002-9440(10)62262-6","journal-title":"Am J Pathol"},{"issue":"40","key":"4130_CR36","doi-asserted-by":"publisher","first-page":"14913","DOI":"10.1073\/pnas.0602045103","volume":"103","author":"SG Park","year":"2006","unstructured":"Park SG, Kang YS, Kim JY, Lee CS, Ko YG, Lee WJ, Lee KU, Yeom YI, Kim S (2006) Hormonal activity of AIMP1\/p43 for glucose homeostasis. Proc Natl Acad Sci USA 103(40):14913\u201314918. https:\/\/doi.org\/10.1073\/pnas.0602045103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4130_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1087-0024.2000.00012.x","volume":"5","author":"J Rak","year":"2000","unstructured":"Rak J, Yu JL, Klement G, Kerbel RS (2000) Oncogenes and angiogenesis: signaling three-dimensional tumor growth. J Investig Dermatol Symp Proc 5(1):24\u201333. https:\/\/doi.org\/10.1046\/j.1087-0024.2000.00012.x","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"10","key":"4130_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101189","volume":"14","author":"S Rakshit","year":"2021","unstructured":"Rakshit S, Sunny JS, George M, Hanna LE, Sarkar K (2021) R-loop modulated epigenetic regulation in T helper cells mechanistically associates coronary artery disease and non-small cell lung cancer. Transl Oncol 14(10):101189. https:\/\/doi.org\/10.1016\/j.tranon.2021.101189","journal-title":"Transl Oncol"},{"issue":"23","key":"4130_CR39","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1182\/blood-2014-07-587642","volume":"124","author":"K Sarkar","year":"2014","unstructured":"Sarkar K, Sadhukhan S, Han SS, Vyas YM (2014) Disruption of hSWI\/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome. Blood 124(23):3409\u20133419. https:\/\/doi.org\/10.1182\/blood-2014-07-587642","journal-title":"Blood"},{"key":"4130_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncomms1601","volume":"2","author":"PC Shukla","year":"2011","unstructured":"Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, Cao L, Rovira II, Pan Y, Brezden-Masley C, Yanagawa B, Gupta A, Deng CX, Coles JG, Leong-Poi H, Stanford WL, Parker TG, Schneider MD, Finkel T, Verma S (2011) BRCA1 is an essential regulator of heart function and survival following myocardial infarction. Nat Commun 2:593. https:\/\/doi.org\/10.1038\/ncomms1601","journal-title":"Nat Commun"},{"issue":"5","key":"4130_CR41","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2174\/1566523215666150818110241","volume":"15","author":"O Shuvalov","year":"2015","unstructured":"Shuvalov O, Petukhov A, Daks A, Fedorova O, Ermakov A, Melino G, Barlev NA (2015) Current genome editing tools in gene therapy: new approaches to treat cancer. Curr Gene Ther 15(5):511\u2013529. https:\/\/doi.org\/10.2174\/1566523215666150818110241","journal-title":"Curr Gene Ther"},{"issue":"37","key":"4130_CR42","doi-asserted-by":"publisher","first-page":"37ra44","DOI":"10.1126\/scitranslmed.3000813","volume":"2","author":"MD Taylor","year":"2010","unstructured":"Taylor MD, Sadhukhan S, Kottangada P, Ramgopal A, Sarkar K, D\u2019Silva S, Selvakumar A, Candotti F, Vyas YM (2010) Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med 2(37):37ra44. https:\/\/doi.org\/10.1126\/scitranslmed.3000813","journal-title":"Sci Transl Med"},{"issue":"2","key":"4130_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF00666040","volume":"36","author":"M Toi","year":"1995","unstructured":"Toi M, Inada K, Suzuki H, Tominaga T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36(2):193\u2013204. https:\/\/doi.org\/10.1007\/BF00666040","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"4130_CR44","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1158\/0008-5472.CAN-09-4713","volume":"70","author":"H Wang","year":"2010","unstructured":"Wang H, Yang ES, Jiang J, Nowsheen S, Xia F (2010) DNA damage-induced cytotoxicity is dissociated from BRCA1\u2019s DNA repair function but is dependent on its cytosolic accumulation. Cancer Res 70(15):6258\u20136267. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4713","journal-title":"Cancer Res"},{"issue":"7481","key":"4130_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A et al (2014) N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481):117\u2013120. https:\/\/doi.org\/10.1038\/nature12730","journal-title":"Nature"},{"issue":"6","key":"4130_CR46","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA et al (2015) N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell 161(6):1388\u20131399. https:\/\/doi.org\/10.1016\/j.cell.2015.05.014","journal-title":"Cell"},{"issue":"1","key":"4130_CR47","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13578-020-00502-3","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang Y, Du Y, Zhou M, Hu Y, Zhang S (2020) Emerging roles of N6-methyladenosine (m6A) modification in breast cancer. Cell Biosci 10(1):136. https:\/\/doi.org\/10.1186\/s13578-020-00502-3 (Published 2020 Nov 25)","journal-title":"Cell Biosci"},{"key":"4130_CR48","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214\u2013W220. https:\/\/doi.org\/10.1093\/nar\/gkq537","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4130_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11764-013-0267-9","volume":"7","author":"KE Weaver","year":"2013","unstructured":"Weaver KE, Foraker RE, Alfano CM et al (2013) Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7(2):253\u2013261. https:\/\/doi.org\/10.1007\/s11764-013-0267-9","journal-title":"J Cancer Surviv"},{"issue":"24","key":"4130_CR50","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/jnci\/84.24.1875","volume":"84","author":"N Weidner","year":"1992","unstructured":"Weidner N, Folkman J, Pozza F et al (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84(24):1875\u20131887. https:\/\/doi.org\/10.1093\/jnci\/84.24.1875","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4130_CR51","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13238-010-0010-5","volume":"1","author":"J Wu","year":"2010","unstructured":"Wu J, Lu LY, Yu X (2010) The role of BRCA1 in DNA damage response. Protein Cell 1(2):117\u2013123. https:\/\/doi.org\/10.1007\/s13238-010-0010-5","journal-title":"Protein Cell"},{"issue":"4","key":"4130_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U et al (2016) Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell 61(4):507\u2013519. https:\/\/doi.org\/10.1016\/j.molcel.2016.01.012 (Published correction appears in Mol Cell. 2016 Mar 17;61(6):925)","journal-title":"Mol Cell"},{"issue":"9","key":"4130_CR53","first-page":"2013","volume":"56","author":"H Yoshiji","year":"1996","unstructured":"Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP (1996) Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 56(9):2013\u20132016","journal-title":"Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04130-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04130-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04130-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T07:10:26Z","timestamp":1666336226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04130-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4130"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04130-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from Institutional Ethics Committee of SRM Medical College Hospital and Research Centre, Kattankulathur, Tamil Nadu 603204, India.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was received from each of the control subject, breast cancer and CAD patients to collect their blood samples.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}